Table 2.
Study reference | Source population | Sample size | Age (years) | Gender (male) | Diagnosis ascertained by an expert panel | Prevalence of pre-HF |
---|---|---|---|---|---|---|
Smeets M et al. 2019 [31••] | General population | 165,796 | ≥ 45 | Not reported | No | 11% |
Jorge AL et al. 2016 [40••] | General population | 633 | Mean ± SD: 59.6 ± 10.4 | 38% | No | 42.7% |
Mureddu GF et al. 2012 [35••]† | General population | 2,001 | 65 to 84 | 51.7% | Yes | 59.1% |
Ghossein-Doha C et al. 2017 [33••] | General population | 41 | Mean ± SD: 40 ± 4 | 0% | No | 7% |
Shah AM et al. 2017 [37••]† | General population | 6,118 | Median (IQR): 75.3 (71.7–77.5) | 42% | Yes | 29.4% |
Xanthakis V et al. 2016 [38••]† | General population | 6,770 |
Mean ± SD: Men: 51 ± 16 Women:51 ± 16 |
46.0% | Yes |
Overall: 24.2% Men: 30.9% Women: 18.5% |
Gupta S et al. 2011 [39••] | General population | 2,277 | Mean ± SD: 47 ± 10 | 57% | No | 12.5% |
Gaborit FS et al. 2019 [32••]† | Patients with hypertension | 400 | Median (range): 72 (67–78) | 51.5% | Yes | 37.5% |
Mureddu GF et al. 2019 [36••] | Patients referred for an echocardiogram | 3,322 | Mean ± SD: 67.1 ± 11.9 | 54.5% | No | 52.6% |
Breetveld NM et al. 2017 [34••] | Pre-eclamptic women | 69 | Median (IQR): 32 (29–35) | 0% | No | 23.2% |
Abbreviations: IQR, interquartile range; SD, standard deviation; US, United States. †The investigators relied on an expert panel to validate the diagnosis of pre−HF